Hao Lou

Hao Lou

Auto-generated profile, based on publicly available information

Hao Lou

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center , Memphis, TN , USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XHXian-Yue Hu
Xian-Yue Hu
HLHao Lou
Hao Lou
MHMichael J. Hageman
Michael J. Hageman

13 June 2013 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
HLH. Lou
H. Lou
MLM. Liu
M. Liu
LWL. Wang
L. Wang
SMS. R. Mishra
S. R. Mishra
WQW. Qu
W. Qu
Hassan AlmoazenHassan Almoazen
Hassan Almoazen

1 January 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HLHao Lou
Hao Lou
JCJohn I. Chung
John I. Chung
YKY.-H. Kiang
Y.-H. Kiang
LXLing-Yun Xiao
Ling-Yun Xiao
MHMichael J. Hageman
Michael J. Hageman

26 April 2013 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
HLHao Lou
Hao Lou
MLMin Liu
Min Liu
WQWen Qu
Wen Qu
ZHZheyi Hu
Zheyi Hu
EBEd Brunson
Ed Brunson
Hassan AlmoazenHassan Almoazen
Hassan Almoazen
Objective: To mask the bitterness of Chlorpheniramine Maleate via encapsulating drug into Eudragit EPO microparticles, and then incorporate these microparticles into orally disintegrating films (ODF) and orally disintegrating tablets (ODT) for pediatric uses. Methods: Spray drying of water-in-oil emulsion was utilized to encapsulate Chlorpheniramine Maleate into Eudragit EPO microparticles. Based on an orthogonal experimental design L9 (33), polynomial regression models were developed to evaluate correlation between microparticle properties (encapsulation efficiency and drug release) and variables (X1: weight ratio of polymer to drug, X2: volume ratio of oil to water and X3: Q-flow of spray dryer). ODF and ODT formulations were evaluated including weight variation, content uniformity, tensile strength, disintegration time, friability and dissolution profiles. The bitterness taste test was evaluated in 10 adult volunteers. Results and discussion: From polynomial regression analysis, the best values of variables leading to the optimized microparticles were X1 = 10, X2 = 3 and X3 = 45. The optimized microparticles were incorporated into ODF and ODT with satisfactory weight and drug content uniformity, and acceptable physical strength. Both dosage forms disintegrated immediately (less than 40 s) in simulated saliva solutions. The outcome of taste-masking test indicated that microparticles alleviated drug bitterness significantly; bitterness was not discernible with microparticles incorporated in ODT, whereas only slight bitterness was detected from microparticles incorporated into ODF. Conclusion: Both ODF and ODT are shown to be suitable vehicles for taste masked Chlorpheniramine Maleate microparticles with potential for pediatric uses.

19 December 2012 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
HLHao Lou
Hao Lou
NQNi Qiu
Ni Qiu
CCCatherine Crill
Catherine Crill
RHRichard Helms
Richard Helms
Hassan AlmoazenHassan Almoazen
Hassan Almoazen

5 May 2020 in Advanced Powder Technology
Verified
Journal Article
Closed access
HLHao Lou
Hao Lou
YKY.-H. Kiang
Y.-H. Kiang
FAFernando Alvarez-Nunez
Fernando Alvarez-Nunez
WLWeikun Li
Weikun Li
MHMichael J. Hageman
Michael J. Hageman